07:49 AM EDT, 10/14/2024 (MT Newswires) -- The French government is considering taking a stake in Sanofi's ( SNY ) consumer health business, which is currently in talks to be sold to US firm Clayton Dubilier & Rice, to protect jobs and production in France, Bloomberg reported on Monday.

The report said that CD&R is close to acquiring a 50% controlling stake in Sanofi's ( SNY ) Opella unit, which is valued at around 15 billion euros ($16.4 billion) and includes popular over-the-counter medications like Doliprane.

"The commitments we will demand will not only be very precise, but they will include guarantees, sanctions, and the means to take stakes that will allow us to ensure the right strategy in terms of health and industrial sovereignty for the country," Finance Minister Antoine Armand told Bloomberg.

Sanofi ( SNY ), CD&R and France Finance Minister's office did not immediately respond to MT Newswires' request for comment.

(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)

Price: 55.18, Change: +0.22, Percent Change: +0.40